User:Jaime.Prilusky/Test/Sortable
From Proteopedia
| Line 1: | Line 1: | ||
| - | <table style="width:100%;padding:20px;border:2px solid #ddd;border-collapse: collapse;"> | + | <table style="width:100%;padding:20px;border:2px solid #ddd;border-collapse: collapse;table-layout: fixed; "> |
<tr><td colspan='4' style="background:#F5F5FC;border:1px solid #ddd;"> | <tr><td colspan='4' style="background:#F5F5FC;border:1px solid #ddd;"> | ||
<span style="font-size:2.0em; border:none; margin:0; padding:0.3em; color:#000;">Welcome to Proteopedia</span><br> | <span style="font-size:2.0em; border:none; margin:0; padding:0.3em; color:#000;">Welcome to Proteopedia</span><br> | ||
| Line 5: | Line 5: | ||
<span style="top:+0.2em; font-size:1.2em; padding-left:5px;">The free, collaborative 3D-encyclopedia of proteins & other molecules<br></span> | <span style="top:+0.2em; font-size:1.2em; padding-left:5px;">The free, collaborative 3D-encyclopedia of proteins & other molecules<br></span> | ||
</td></tr> | </td></tr> | ||
| - | <tr style="font-size: | + | <tr style="padding:5px;font-size:2em; text-align:center; font-weight: bold; "> |
<td>Journals</td><td>Art on Science</td><td>Selected Pages</td><td>Education</td></tr> | <td>Journals</td><td>Art on Science</td><td>Selected Pages</td><td>Education</td></tr> | ||
| - | <tr><td> | + | <tr> |
| + | <td> {{Proteopedia:Featured article/{{#expr: {{#time:U}} mod {{Proteopedia:Number of featured articles}}}}}}</td> | ||
| + | <td> {{Proteopedia:Featured article/{{#expr: {{#time:U}} mod {{Proteopedia:Number of featured articles}}}}}}</td> | ||
| + | <td> {{Proteopedia:Featured article/{{#expr: {{#time:U}} mod {{Proteopedia:Number of featured articles}}}}}}</td> | ||
| + | <td> {{Proteopedia:Featured article/{{#expr: {{#time:U}} mod {{Proteopedia:Number of featured articles}}}}}}</td> | ||
| + | </tr> | ||
</table> | </table> | ||
Revision as of 21:01, 16 February 2018
|
Welcome to Proteopedia | |||||||||||||||||||||||||||||||||||||||||||
| Journals | Art on Science | Selected Pages | Education | ||||||||||||||||||||||||||||||||||||||||
by Eric Martz
H5N1 bird flu has seemed a likely pandemic threat for decades, but the first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug oseltamivir (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. Luckily H1N1 swine flu is susceptible (at least in early May, 2009). The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase. Neuraminidase is a homotetramer, shown with oseltamivir bound (). Here is . Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1, doing so by (induced fit). The most common mutation in N1 that confers resistance to oseltamivir is H274Y. The mutant tyrosine prevents oseltamivir from fitting, but still allows . (more...) |
by Eric Martz
H5N1 bird flu has seemed a likely pandemic threat for decades, but the first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug oseltamivir (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. Luckily H1N1 swine flu is susceptible (at least in early May, 2009). The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase. Neuraminidase is a homotetramer, shown with oseltamivir bound (). Here is . Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1, doing so by (induced fit). The most common mutation in N1 that confers resistance to oseltamivir is H274Y. The mutant tyrosine prevents oseltamivir from fitting, but still allows . (more...) |
by Eric Martz
H5N1 bird flu has seemed a likely pandemic threat for decades, but the first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug oseltamivir (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. Luckily H1N1 swine flu is susceptible (at least in early May, 2009). The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase. Neuraminidase is a homotetramer, shown with oseltamivir bound (). Here is . Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1, doing so by (induced fit). The most common mutation in N1 that confers resistance to oseltamivir is H274Y. The mutant tyrosine prevents oseltamivir from fitting, but still allows . (more...) |
by Eric Martz
H5N1 bird flu has seemed a likely pandemic threat for decades, but the first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug oseltamivir (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. Luckily H1N1 swine flu is susceptible (at least in early May, 2009). The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase. Neuraminidase is a homotetramer, shown with oseltamivir bound (). Here is . Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1, doing so by (induced fit). The most common mutation in N1 that confers resistance to oseltamivir is H274Y. The mutant tyrosine prevents oseltamivir from fitting, but still allows . (more...) |
||||||||||||||||||||||||||||||||||||||||
